HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Kidney Cancer

Kidney cancer, also known as renal cell carcinoma, is a type of cancer that originates in the kidneys – the vital organs responsible for filtering waste products and excess fluids from the blood to form urine. This form of cancer typically develops in the lining of small tubes within the kidneys, leading to the formation of tumors. The exact cause of kidney cancer is often challenging to pinpoint, but certain risk factors may increase the likelihood of its development. These factors include smoking, obesity, high blood pressure, and a family history of kidney cancer. Additionally, certain genetic conditions and long-term dialysis treatment may also contribute to an increased risk. Symptoms of kidney cancer may not manifest in the early stages, but as the disease progresses, individuals may experience symptoms such as blood in the urine, persistent back pain just below the ribs, unintentional weight loss, fatigue, and a lump or swelling in the abdomen. Diagnosis of kidney cancer typically involves a combination of imaging tests, such as CT scans or MRIs, and a biopsy to confirm the presence of cancerous cells. Treatment options for kidney cancer depend on various factors, including the stage of cancer, overall health, and individual preferences. Common approaches include surgery to remove the tumor or the entire kidney, targeted therapy, immunotherapy, and in some cases, radiation therapy. Prognosis for kidney cancer varies, but early detection and intervention often lead to better outcomes. Regular check-ups, especially for individuals with known risk factors, can contribute to the early identification of any potential issues. As with any cancer, a multidisciplinary approach involving oncologists, surgeons, and other healthcare professionals is crucial for comprehensive and personalized care. In conclusion, kidney cancer is a serious condition that requires careful attention and prompt medical intervention. Understanding risk factors, recognizing potential symptoms, and seeking timely medical advice are crucial steps in managing this disease.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp